Uluru
Addison, US · Nevada corporation · 1 known investors
Founders & leadership
TK
Terrance K. WallbergExecutive
KP
Kerry P. GrayExecutive
Board
JB
Jeffrey B. DavisBoard director
HK
Helmut KerschbaumerBoard director
KK
Klaus KuehneBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$12.2M disclosed across 7 rounds · 2014–2023
▶$2.2MraisedSep 2023 · 2 investors · Other Health CareRule 506(b)
▶$2.2MraisedSep 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Oksana TiedtExecutive Officer, Director
- Bradley SacksDirector
- Vaidehi ShahExecutive Officer, Director
- Anish ShahExecutive Officer, Director
- Robert MandellDirector
- Offering amount
- $6.6M
- Amount sold
- $2.2M
- Minimum investment
- $250K
- First sale
- Jun 2023
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$690KraisedNov 2019 · 4 investors · Other Health CareRule 506(b)
▶$690KraisedNov 2019 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dane ShacklefordExecutive Officer
- Oksana TiedtDirector
- PK RamachandranExecutive Officer
- Bradley SacksDirector
- Arindam BoseDirector
- Anish ShahExecutive Officer, Director
- Vaidehi ShahExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $690K
- Minimum investment
- $25K
- First sale
- Nov 2019
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$5.5MraisedApr 2017 · 2 investors · Other Health CareRule 506(b)
▶$5.5MraisedApr 2017 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Bradley J. SacksDirector
- Terrance K. WallbergExecutive Officer
- Anish Vithaldas ShahDirector
- Vaidehi ShahExecutive Officer, Director
- Oksana TiedtDirector
- Arindam BoseDirector
- Offering amount
- $5.5M
- Amount sold
- $5.5M
- First sale
- Mar 2017
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.7MraisedApr 2016 · 15 investors · PharmaceuticalsRule 506(b)
▶$1.7MraisedApr 2016 · 15 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bradley J. SacksDirector
- Klaus KuehneDirector
- Robert F. GoldrichDirector
- Helmut KerschbaumerExecutive Officer, Director
- Terrance K. WallbergExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.7M
- Finders' fees
- $26K
- First sale
- Mar 2016
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.6MraisedSep 2015 · 5 investors · PharmaceuticalsRule 506(b)
▶$1.6MraisedSep 2015 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kerry P. GrayExecutive Officer, Director
- Klaus KuehneDirector
- Helmut KerschbaumerDirector
- Jeffrey B. DavisDirector
- Bradley J. SacksDirector
- Terrance K. WallbergExecutive Officer
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- Finders' fees
- $186K
- Placement agents
- Lang & Schwarz Broker GmbH
- First sale
- Sep 2015
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$500KraisedApr 2015 · 1 investors · PharmaceuticalsRule 506(b)
▶$500KraisedApr 2015 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Klaus KuehneDirector
- Jeffrey B. DavisDirector
- Helmut KerschbaumerDirector
- Terrance K. WallbergExecutive Officer
- Kerry P. GrayExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Apr 2015
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$42.6KraisedMar 2014 · 1 investors · PharmaceuticalsRule 506(b)
▶$42.6KraisedMar 2014 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Klaus KuehneDirector
- Jeffrey B. DavisDirector
- Terrance K. WallbergExecutive Officer
- Kerry P. GrayExecutive Officer, Director
- Helmut KerschbaumerDirector
- Offering amount
- $138.6K
- Amount sold
- $42.6K
- First sale
- Feb 2014
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Uluru's investors?
- Uluru's investors include Velocitas.
- How much funding has Uluru raised?
- Uluru has disclosed $12.2M raised across 7 rounds.
- Where is Uluru headquartered?
- Uluru is headquartered in Addison, US.